4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0000947871-16-001312
Director bought 550,000 shares at $14.00 ($7,700,000)
- Director acquired 1,177,995 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
ORBIMED ADVISORS LLC · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-06-27 | Conversion : show line 1 in the form | +11,111 | 12,193 | I | ||
| 2016-06-27 | Conversion : show line 2 in the form | +1,166,884 | 1,280,604 | I | ||
| 2016-06-27 | Purchase : show line 3 in the form | +5,189 | $14.00 | $72,646 | 17,382 | I |
| 2016-06-27 | Purchase : show line 4 in the form | +544,811 | $14.00 | $7,627,354 | 1,825,415 | I |
| Open-market purchases · 550,000 sh · avg $14.00 · $7,700,000 | ||||||
Table II: Derivative
6 lines| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2016-06-27 | Conversion : show line 5 in the form Series C Convertible Preferred Stock | −3,628 | 3,628 | 0 | I |
| 2016-06-27 | Conversion : show line 6 in the form Series C Convertible Preferred Stock | −380,986 | 380,986 | 0 | I |
| 2016-06-27 | Conversion : show line 7 in the form Series D Convertible Preferred Stock | −739 | 739 | 0 | I |
| 2016-06-27 | Conversion : show line 8 in the form Series D Convertible Preferred Stock | −77,697 | 77,697 | 0 | I |
| 2016-06-27 | Conversion : show line 9 in the form Series E Convertible Preferred Stock | −4,351 | 6,744 | 0 | I |
| 2016-06-27 | Conversion : show line 10 in the form Series E Convertible Preferred Stock | −456,870 | 708,201 | 0 | I |
Loading xslF345X03/ss732_4.xml…